Results 171 to 180 of about 131,276 (280)
This systematic review aims to determine whether MVS reduces the incidence of VA and SCD in patients with MVP. Available studies show a likely reduction when surgery is performed in line with current guideline‐directed indications; however, a residual risk of VA and SCD remains.
James N. Cameron+12 more
wiley +1 more source
Abstract Lung cancer is the leading cause of cancer‐related death globally. To better understand the biology of lung cancer, mouse models have been developed using either tail vein‐injected tumour cell lines or genetically modified mice. The current gold‐standard models typically present with multiple lung foci.
Ana‐Rita Pedrosa+20 more
wiley +1 more source
DETECTION OF RADIONUCLIDE CONTAMINATION ON FACE MASKS
E.M. Sheen, G.D. Crouch
openalex +2 more sources
Peptide‐Drug Conjugates: A New Hope for Cancer
Peptide‐drug conjugates (PDCs) are emerging cancer therapeutics inspired by antibody‐drug conjugates, offering targeted delivery via peptide ligands. Despite structural versatility, challenges like instability and rapid clearance hinder clinical progress.
Amy Armstrong+3 more
wiley +1 more source
85Sr Radionuclide Scintimetry in Infected Total Hip Arthroplasty [PDF]
Göran C. H. Bauer+3 more
openalex +1 more source
ABSTRACT Aim To explore the possibility of reducing the diagnostic burden in children with prenatally detected unilateral ureteropelvic junction obstruction. Methods Children with unilateral ureteropelvic junction obstruction (2012–2020) were identified from a prenatal hydronephrosis registry.
Tim Malmström+4 more
wiley +1 more source
Assessment of central blood volume in cirrhosis by radionuclide angiography [PDF]
Bendtsen, Flemming+10 more
core
Production reactor process tube film composition and radionuclide inventory studies. Status report
L.D. Perrigo
openalex +1 more source